The Netherlands Journal of Medicine 1992: Vol 41 Index

6 Pages·1992·1.7 MB·English

Netherlands Journal of Medicine, 41 (1992) 309-310 309
© 1992 Elsevier Science Publishers B.V. All rights reserved 0300-/2929 /7$057.0 0
Subject Index Volume 41
ACTH ,4_o, (41) 255 Energy, (41) 127
Adrenal cortical carcinoma, (41) 280 Eosinophilic pneumonia, (41) 153
Adrenocortical carcinoma, (41) 161 Epidemiology, (41) 149
Adverse effects, (41) 153 Episodic fever, (41) 158
AIDS, complications, (41) 68 Erythrocyte, (41) 245
Amylin, (41) 82 Erythropoietin, (41) 56
Amyloid, (41) 264 Exercise, (41) 284
Anti C-100-3 antibodies, (41) 36 Fever of unknown origin, (41) 158, (41) 218
Aplastic anaemia, (41) 143 Fibrosing alveolitis, (41) 153
5-ASA, (41) 71 Fluconazole, adverse effects, (41) 68
Biliary tract, (41) 123 Food intake and mood, (41) 45
Blood pressure, (41) 48 Gallbladder, (41) 123
Bone density, (41) 259 Gastroenterology, (41) 93
Bone mass, (41) 259 Genetics, (41) 115
Calcaemia, (41) 82 Genotype, (41) 97
Calcium supplementation, (41) 48 Glucose, (41) 208
Cancer, (41) 208 Glucose production, (41) 82
CAPD, (41) 137 Glucose uptake, (41) 82
Carbohydrates, (41) 45 Graft survival, (41) 194
Carcinoid, (41) 17 Growth, (41) 127
Chloride secretion, (41) 110, (41) 115 Growth hormone, (41) 28, (41) 229
Cholecystokinin, (41) 123 Hand bones, (41) 259
Chronic lymphocytic leukaemia, (41) 64 Heart failure, (41) 171
Chronic obstructive pulmonary disease, (41) 74 Hepatitis C, (41) 36
Colorectal cancer, (41) 22 Hepatobiliary complications, (41) 93
Complement receptor type 1 (CR1), (41) 245 Hip fracture, (41) 4
Controlled trial, (41) 48 Histiocytic necrotizing lymphadenitis, (41) 222
Coronary artery disease, (41) 284 Hypogonadotrophic hypogonadism, (41) 259
Coronary perfusion, (41) 171 Immune adherence, (41) 245
Critically ill patient, (41) 229 Immune complex, (41) 245
Cyclosporine, (41) 143 Immunosuppression, (41) 194
Cystic fibrosis, (41) 93, (41) 97, (41) 101, (41) 105, (41) 110, Indirect immunofluorescence assay, (41) 222
(41) 115, (41) 119, (41) 123, (41) 127, (41) 130 Inhibitors, (41) 56
Cytokines, (41) 295 Insulin action, (41) 82
o,p’-DDD, (41) 161 Insulin-dependent diabetes mellitus, (41) 28
Dengue virus, (41) 272 Insulin-like growth factor, (41) 229
Deoxycorticosterone, (41) 280 Insulin-like growth factor I, (41) 28
Desferrioxamine, (41) 275 Insulinoma, (41) 264
Diabetes, (41) 82 Insulin secretion, (41) 82
Diabetes-associated peptide (DAP), (41) 82 Intestinal epithelium, (41) 115
Diabetes mellitus, (41) 191 Intestinal obstruction, (41) 110
Diabetic neuropathy, (41) 255 Islet amyloid polypeptide (IAPP), (41) 82, (41) 264
Diagnosis of hepatitis C, (41) 36 Kallmann, (41) 259
Dialysis, (41) 275 Kikuchi’s lymphadenitis, (41) 222
Dipyridamole, (41) 284 Leukaemic infiltration of the kidneys, (41) 64
Eating disorder, (41) 45 Leukopenia, (41) 272
Echocardiography, (41) 17 Life expectancy, (41) 130
Endothelium, (41) 183 Liver disease, (41) 119
310
Lung function, (41) 130 Primary biliary cirrhosis, (41) 11
Malabsorption, (41) 24, (41) 93, (41) 110 Prognosis, (41) 93
Malnutrition, (41) 127, (41) 130 Protein metabolism, (41) 229
Mesalamine, (41) 71 Psychogenic fever, (41) 158
Metacarpal bone, (41) 259 Pyrexia, (41) 22
Mineralocorticoid excess, (41) 280 Quality control, (41) 137
Morbidity, (41) 194 Raynaud’s phenomenon, (41) 149
Mortality, (41) 4 Regulatory defects, (41) 295
Mucormycosis, (41) 275 Rejection, (41) 194
Myocardial hypertrophy, (41) 171 Renal failure, (41) 56, (41) 64
Neuropeptide, (41) 255 Respiratory muscles, (41) 74
Nutritional state, (41) 130 Sepsis, (41) 208
Obesity, (41) 82 Serotonin, (41) 183
Omeprazole, (41) 105 Serum total calcium, (41) 48
Osteoporosis, (41) 82 Stagnant loop, (41) 24
Ovarian carcinosarcoma, (41) 161 Sulphasalazine, (41) 153
Oxygen radicals, (41) 275 Survival, (41) 127
Paget’s disease, (41) 82 Systemic lupus erythematosus, (41) 245
Pancreas, (41) 101 Therapeutic use of corticosteroids, (41) 161
Pancreas transplantation, (41) 191, (41) 194 Thrombocytopenia, (41) 272
Pancreatic enzymes, (41) 105 Thrombosis, (41) 183
Pancreatic function, (41) 101 Transoesophageal imaging, (41) 17
Pancreatic insufficiency, (41) 97, (41) 105 Tubeless test, (41) 101
Pancreatitis, (41) 71 Tuberculosis, (41) 218
Paresis, (41) 218 Ursodeoxycholic acid, (41) 11, (41) 119
Peritonitis, (41) 218 Ventral hernia, (41) 24
Platelets, (41) 183 Yersinia enterocolitica, (41) 222
Polycythaemia vera, (41) 295 Zidovudine, adverse effects, (41) 68
Porphyria cutanea tarda, (41) 68
Netherlands Journal of Medicine, 41 (1992) 311-313
© 1992 Elsevier Science Publishers B.V. All rights reserved 0300-/2929 /7$057.0 0
Author Index Volume 41
Ackerman, E., see Erdkamp, F. (41) 71 De Wolf, J.T.M., Vellenga, E. and Halie, M.R.
Andriessen, M.P.H.M., see Van Veldhuisen, D.J. (41) 17 Polycythaemia vera (41) 295
Apostolo, M.G., see Colombo, C. (41) 119 D’haene, E.G., see Niemeyer, M.G. (41) 284
Assaisso, M., see Colombo, C. (41) 119 Dodge, J.A.
Malnutrition and age-specific nutritional management in
Backer, E.T., see Van Aalderen, W. (41) 161
cystic fibrosis (41) 127
Bakker, A.J., see Bijl, M. (41) 280 Drake-Holland, A.J., see Noble, M.I.M. (41) 183
Bakker, W. Durie, P.R.
Nutritional state and lung disease in cystic fibrosis (41) 130
Pathophysiology of the pancreas in cystic fibrosis (41) 97
Barge, R.M.Y., see Koopmans, S.J. (41) 82
Duurkens, V.A.M., see Timmer, R. (41) 153
Bartelink, M.L., Wollersheim, H., Van de Lisdonk, E., Spruijt, Duursma, S.A., see Boereboom, F.T.J. (41) 4
R. and Van Weel, C.
Prevalence of Raynaud’s phenomenon (41) 149
Erdkamp, F., Houben, M., Ackerman, E., Breed, W. and
Berends, M.J.H., see Nieuwenhuis, M.G. (41) 264
Van Spreeuwel, J.
Bijl, M., Bakker, A.J. and Leemhuis, M.P.
Pancreatitis induced by mesalamine (41) 71
Mineralocorticoid excess due to precursors only in a pa-
Erkelens, D.W., see Bravenboer, B. (41) 255
tient with adrenal cortical carcinoma (41) 280
Boereboom, F.T.J., Raymakers, J.A. and Duursma, S.A.
Fevery, J., see Willems, M. (41) 36
Mortality and causes of death after hip fractures in The
Fireman, Z., see Cohen, A.M. (41) 24
Netherlands (41) 4
Folgering, H.T.M., see Dekhuijzen, P.N.R. (41) 74
Boeschoten, E.W.
After 16 years: quality assessment in CAPD (41) 137
Gelvan, A., see Cohen, A.M. (41) 24
Bot, A., see Van der Werff ten Bosch, J.J. (41) 259
Gispen, W.H., see Bravenboer, B. (41) 255
Bottani, P., see Colombo, C. (41) 119
Gooszen, H.G., see Van Oosterhout, E.C.A.A. (41) 194
Brandt, K.-H., see Kneppelhout, J.C. (41) 11
Goudsmit, R., see Leeksma, O.C. (41) 143
Bravenboer, B., Erkelens, D.W. and Gispen, W.H.
Rationale for the use of the ACTH, _, analogue ORG
Haanen, C., see Haraldsdottir, V. (41) 64
2766 in the treatment of diabetic neuropathy (41) 255
Halie, M.R., see De Wolf, J.T.M. (41) 295
Breed, W., see Erdkamp, F. (41) 71
Halma, C., Van Es, L.A. and Daha, M.R.
Brennan, M.F., see Sauerwein, H.P. (41) 208
A newly discovered function of the erythrocyte: transport
Brenninkmeijer, B.J., see Vreden, S.G.S. (41) 218
of immune complexes to the liver (41) 245
Hamer, J.P.M., see Van Veldhuisen, D.J. (41) 17
Chang, P.C., see Van Aalderen, W. (41) 161
Haraldsdottir, V., Haanen, C. and Jordans, J.G.M.
Cohen, A.M., Maran, R., Gelvan, A., Fireman, Z. and Lurie,
Chronic lymphocytic leukaemia presenting as renal failure
B.
with lymphocytic infiltration of the kidneys (41) 64
Malabsorption due to a ventral hernia (41) 24
Heijerman, H.G.M.
Colombo, C., Apostolo, M.G., Assaisso, M., Roman, B. and
Gastroenterological aspects of cystic fibrosis (41) 93
Bottani, P.
Heijerman, H.G.M.
Liver disease in cystic fibrosis (41) 119
New modalities in the treatment of exocrine pancreatic
Daha, M.R., see Halma, C. (41) 245 insufficiency in cystic fibrosis (41) 105
De Boer, H., see Voerman, H.J. (41) 229 Heijerman, H.G.M., see Jebbink, M.C.W. (41) 123
Dekhuijzen, P.N.R., Folgering, H.T.M. and Van Herwaarden, Heikens, J., Tel, W., Van de Stadt, J.. De Koning, J. and
C.L.A. Ten Napel, C.H.H.
Chronic airflow obstruction, hyperinflation and the respi- Kikuchi’s lymphadenitis: report of a Yersinia enterocoliti-
ratory muscles (41) 74 ca-associated case and an overview of aetiology and clini-
De Koning, J., see Heikens, J. (41) 222 cal outcome (41) 222
De Vries, E.G.E., see Van Veldhuisen, D.J. (41) 17 Hillen, P.H., see Van Dullemen, H.M. (41) 56
De Vries, R.A., see Kneppelhout, J.C. (41) 11 Houben, M., see Erdkamp, F. (41) 71
312
Ilan, Y. and Shalit, M. Nieuwenhuis, M.G., Van Mansfeld, A.D.M., Van Unnik,
Pyrexia of unknown origin as the only manifestation of J.A.M., Berends, M.J.H. and Lips, C.J.M.
colorectal carcinoma (41) 22 No constant relationship between islet amyloid polypep-
tide (IAPP) and insulin expression in insulinomas (41) 264
Noble, M.I.M. and Drake-Holland, A.J.
Jebbink, M.C.W., Heijerman, H.G.M., Masclee, A.A.M. and
The possible role of serotonin SHT, receptor antagonism
Lamers, C.B.H.W.
in cardioprotection (41) 183
Gallbladder disease in cystic fibrosis (41) 123
Noordzij, H.M., see Timmerman, R.J. (41) 158
Jordans, J.G.M., see Haraldsdottir, V. (41) 64
Pauwels, E.K.J., see Niemeyer, M.G. (41) 284
Kauffmann, R.H., see Melissant, C.F. (41) 272
Pesola, G.R., see Sauerwein, H.P. (41) 208
Kauffmann, R.H., see Seeverens, H.J.J. (41) 275
Pijl, H., see Toornvliet, A.C. (41) 45
Kazzaz, B.A., see Seeverens, H.J.J. (41) 275
Kneppelhout, J.C., Mulder, C.J.J., Van Berge Henegouwen,
Radder, J.K., see Koopmans, S.J. (41) 82
G.P., De Vries, R.A. and Brandt, K.-H.
Raymakers, J.A., see Boereboom, F.T.J. (41) 4
Ursodeoxycholic acid treatment in primary biliary cirrhosis
Remme, W.J.
with the emphasis on late stage disease (41) 11
Pathophysiology and therapy of heart failure, new insights
Koopmans, S.J., Radder, J.K., Krans, H.M.J. and Barge,
and developments. Part I (41) 171
R.M.Y.
Roman, B., see Colombo, C. (41) 119
Biological action of pancreatic amylin: relationship with
Ruijs, G.J.H.M., see Seeverens, H.J.J. (41) 275
glucose metabolism, diabetes, obesity and calcium
Russel, M.G.V.M., Lustermans, F.A.T., Wuite, J. and
metabolism (41) 82
Van Pelt, J.
Krans, H.M.J., see Koopmans, S.J. (41) 82
Porphyria cutanea tarda in a patient with AIDS (41) 68
Lamers, C.B.H.W.
Sauerwein, H.P., Pesola, G.R. and Brennan, M.F.
Tubeless tests of exocrine pancreatic function in patients
Lowering of plasma glucose concentration in septic can-
with cystic fibrosis (41) 101
cer-bearing patients: metabolic significance (41) 208
Lamers, C.B.H.W., see Jebbink, M.C.W. (41) 123
Schaper, N.C.
Leeksma, O.C., Thomas, L.L.M., Van der Lelie, J., Van Oers,
Growth hormone and insulin-dependent diabetes mellitus
M.H.J., Von dem Borne, A.E.G.K. and Goudsmit, R.
(41) 28
Effectiveness of low dose cyclosporine in acquired aplastic
Seeverens, H.J.J., Tijhuis, G.J., Ruijs, G.J.H.M., Kazzaz, B.A.
anaemia with severe neutropenia (41) 143
and Kauffmann, R.H.
Leemhuis, M.P., see Bijl, M. (41) 280
Dialysis associated mucormycosis and desferrioxamine
Lemkes, H.H.P.J., see Van Oosterhout, E.C.A.A. (41) 194
treatment: a case report with review of the role of oxygen
Lie, K.I., see Van Veldhuisen, D.J. (41) 17
radicals (41) 275
Lips, C.J.M., see Nieuwenhuis, M.G. (41) 264
Shalit, M., see Ilan, Y. (41) 22
Lurie, B., see Cohen, A.M. (41) 24
Sinaasappel, M.
Lustermans, F.A.T., see Russel, M.G.V.M. (41) 68
Relationship between intestinal function and chloride se-
Luykx-de Bakker, S., see Van Dullemen, H.M. (41) 56
cretion in patients with cystic fibrosis (41) 110
Lyle, R.M.
Spruijt, R., see Bartelink, M.L. (41) 149
Does baseline serum total calcium level influence the
Strack van Schijndel, R.J.M., see Voerman, H.J. (41) 229
blood pressure response to calcium supplementation? A
double-blind study (41) 48
Tamsma, J.T., see Van Oosterhout, E.C.A.A. (41) 194
Tel, W., see Heikens, J. (41) 222
Maran, R., see Cohen, A.M. (41) 24
Ten Napel, C.H.H., see Heikens, J. (41) 222
Masclee, A.A.M., see Jebbink, M.C.W. (41) 123
Terpstra, J.L., see Van Oosterhout, E.C.A.A. (41) 194
Meinders, A.E., see Toornvliet, A.C. (41) 45
Thijs, L.G., see Voerman, H.J. (41) 229
Melissant, C.F. and Kauffmann, R.H.
Thomas, L.L.M., see Leeksma, O.C. (41) 143
Infection with Dengue virus (41) 272
Thompson, J., see Timmerman, R.J. (41) 158
Moolenaar, A.J., see Van Aalderen, W. (41) 161
Tijhuis, G.J., see Seeverens, H.J.J. (41) 275
Moshage, H., see Willems, M. (41) 36
Timmer, R., Duurkens, V.A.M. and Van Hees, P.A.M.
Mulder, C.J.J., see Kneppelhout, J.C. (41) 11
Sulphasalazine-induced eosinophilic pneumonia (41) 153
Timmerman, R.J., Thompson, J., Noordzij, H.M. and
Niemeyer, M.G., Van der Wall, E.E., D’haene, E.G., Van der Meer, J.W.M.
Van Rugge, F.P. and Pauwels, E.K.J. Psychogenic periodic fever (41) 158
Alternative stress methods for the diagnosis of coronary Toornvliet, A.C., Pijl, H. and Meinders, A.E.
artery disease (41) 284 Food and mood: a central connection (41) 45
313
Van Aalderen, W., Van Seters, A.P., Backer, E.T., Chang, Van Oosterhout, E.C.A.A., Van der Woude, F.J., Lemkes,
P.C., Van Krieken, J.H.J.M. and Moolenaar, A.J. H.H.P.J., Gooszen, H.G., Van Bronswijk, H., Van den
A case of recurrent adrenocortical carcinoma, with obser- Akker, P.J., Tamsma, J.T. and Terpstra, J.L.
vations on long-term 0,p’-DDD therapy and complications Simultaneous pancreas and kidney transplantation: a fea-
(41) 161 sible procedure in selected patients (41) 194
Van Berge Henegouwen, G.P., see Kneppelhout, J.C. (41) 11 Van Pelt, J., see Russel, M.G.V.M. (41) 68
Van Boven, W.P.L., see Van Dullemen, H.M. (41) 56 Van Rugge, F.P., see Niemeyer, M.G. (41) 284
Van Bronswijk, H., see Van Oosterhout, E.C.A.A. (41) 194 Van Seters, A.P., see Van Aalderen, W. (41) 161
Van de Lisdonk, E., see Bartelink, M.L. (41) 149 Van Spreeuwel, J., see Erdkamp, F. (41) 71
Van den Akker, P.J., see Van Oosterhout, E.C.A.A. (41) 194 Van Unnik, J.A.M., see Nieuwenhuis, M.G. (41) 264
Van der Heul, C., see Van Dullemen, H.M. (41) 56 Van Veldhuisen, D.J., Hamer, J.P.M., Andriessen, M.P.H.M.,
Van der Lelie, J., see Leeksma, O.C. (41) 143 De Vries, E.G.E. and Lie, K.I.
Van der Meer, J.W.M., see Timmerman, R.J. (41) 158 Additive value of transoesophageal echocardiography in
Van der Meer, J.W.M., see Vreden, S.G.S. (41) 218 the visualization of carcinoid heart disease (41) 17
Van der Veen, E.A., see Voerman, H.J. (41) 229 Van Weel, C., see Bartelink, M.L. (41) 149
Van der Wall, E.E., see Niemeyer, M.G. (41) 284 Veeze, H.J.
Van der Werff ten Bosch, J.J. and Bot, A. Cystic fibrosis: genetics and intestinal secretion (41) 115
Some skeletal dimensions of males with isolated go- Vellenga, E., see De Wolf, J.T.M. (41) 295
nadotrophin deficiency (41) 259 Voerman, H.J., Strack van Schijndel, R.J.M., De Boer, H.,
Van der Woude, F.J., see Van Oosterhout, E.C.A.A. (41) 194 Van der Veen, E.A. and Thijs, L.G.
Van de Stadt, J., see Heikens, J. (41) 222 Growth hormone: secretion and administration in catabolic
Van Dullemen, H.M., Luykx-de Bakker, S., Hillen, P.H., adult patients, with emphasis on the critically ill patient
Van Landeghem, A.A.J., Van Boven, W.P.L. and (41) 229
Van der Heul, C. Von dem Borne, A.E.G.K., see Leeksma, O.C. (41) 143
Inhibitors of recombinant human erythropoietin in chronic Vreden, S.G.S., Brenninkmeijer, B.J. and Van der Meer,
renal failure (41) 56 J.W.M.
Van Es, L.A., see Halma, C. (41) 245 Peritoneal tuberculosis in two young immigrants with fever
Van Hees, P.A.M., see Timmer, R. (41) 153 of unknown origin (41) 218
Van Herwaarden, C.L.A., see Dekhuijzen, P.N.R. (41) 74
Van Hooff, J.P.
Willems, M., Moshage, H., Fevery, J. and Yap, S.H.
Pancreas transplantation: from experiment to therapy (41)
Hepatitis C (41) 36
191
Wollersheim, H., see Bartelink, M.L. (41) 149
Van Krieken, J.H.J.M., see Van Aalderen, W. (41) 161
Wuite, J., see Russel, M.G.V.M. (41) 68
Van Landeghem, A.A.J., see Van Dullemen, H.M. (41) 56
Van Mansfeld, A.D.M., see Nieuwenhuis, M.G. (41) 264
Van Oers, M.H.J., see Leeksma, O.C. (41) 143 Yap, S.H., see Willems, M. (41) 36